Research graph
References from Quantitative and qualitative differences in anti-Envelope IgG-secreting cells distinguish subclinical and hospitalized dengue in a Cambodian pediatric cohort. Local targets link to admitted publications; unresolved targets remain external evidence.
The current and future global distribution and population at risk of dengue
10.1038/s41564-019-0476-8 · 2019 · External reference
Global burden for dengue and the evolving pattern in the past 30 years
10.1093/jtm/taab146 · 2021 · External reference
Global prevalence of asymptomatic dengue infections - a systematic review and meta-analysis
10.1016/j.ijid.2023.07.010 · 2023 · External reference
Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections
10.3389/fimmu.2014.00280 · 2014 · External reference
Unresolved reference
2009 · External reference
Dengue
10.1016/s0140-6736(23)02576-x · 2024 · External reference
The global distribution and burden of dengue
10.1038/nature12060 · 2013 · External reference
A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand
10.1093/infdis/jit436 · 2014 · External reference
Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year
10.1371/journal.pntd.0002357 · 2013 · External reference
Homotypic dengue virus reinfections in Nicaraguan children
10.1093/infdis/jiw099 · 2016 · External reference
Effect of the tetravalent dengue vaccine TAK-003 on sequential episodes of symptomatic dengue
10.4269/ajtmh.22-0673 · 2023 · External reference
Dengue
10.1016/s0140-6736(07)61687-0 · 2007 · External reference
Epidemiologic studies on dengue in Santiago de Cuba, 1997
10.1093/aje/152.9.793 · 2000 · External reference
The role of IgG Fc receptors in antibody-dependent enhancement
10.1038/s41577-020-00410-0 · 2020 · External reference
Immunological enhancement of dengue virus replication
1973 · External reference
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
10.1016/s1473-3099(10)70166-3 · 2010 · External reference
Human FcγRIIIa activation on splenic macrophages drives dengue pathogenesis in mice
10.1038/s41564-023-01421-y · 2023 · External reference
Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans
10.1111/tra.12012 · 2013 · External reference
Antibody-dependent enhancement of severe dengue disease in humans
10.1126/science.aan6836 · 2017 · External reference
Cross-reacting antibodies enhance dengue virus infection in humans
10.1126/science.1185181 · 2010 · External reference
Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention
10.1073/pnas.0703498104 · 2007 · External reference
Antigenic distance between primary and secondary dengue infections correlates with disease risk
10.1126/scitranslmed.adk3259 · 2024 · External reference
Serotype-specific epidemiological patterns of inapparent versus symptomatic primary dengue virus infections: A 17-year cohort study in Nicaragua
10.1016/s1473-3099(24)00566-8 · 2025 · External reference
Maternal anti-dengue IgG fucosylation predicts susceptibility to dengue disease in infants
10.1016/j.celrep.2020.107642 · 2020 · External reference
Antibody fucosylation predicts disease severity in secondary dengue infection
10.1126/science.abc7303 · 2021 · External reference
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection
10.1038/s41467-024-45806-x · 2024 · External reference
The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design
10.15252/embr.201745302 · 2018 · External reference
Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification
10.1371/journal.ppat.1000790 · 2010 · External reference
Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera
10.1371/journal.ppat.1004386 · 2014 · External reference
Dengue virus envelope epitope-specific antibodies are associated with protection from severe dengue
10.1038/s44321-026-00485-7 · 2026 · External reference
The epitope arrangement on flavivirus particles contributes to Mab C10’s extraordinary neutralization breadth across Zika and dengue viruses
10.1016/j.cell.2021.11.010 · 2021 · External reference
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
10.1073/pnas.1200566109 · 2012 · External reference
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
10.1038/ncomms15411 · 2017 · External reference
Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients
10.4049/jimmunol.1103350 · 2013 · External reference
Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans
10.1128/jvi.06075-11 · 2012 · External reference
Immune profiling in subclinical secondary dengue-infected cases reveals adaptive immune signatures correlated to protection from severe dengue
10.1016/j.chom.2025.06.006 · 2025 · External reference
Plasmablasts during acute dengue infection represent a small subset of a broader virus-specific memory B cell pool
10.1016/j.ebiom.2016.09.003 · 2016 · External reference
In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection
10.1371/journal.pntd.0001188 · 2011 · External reference
B cell responses during secondary dengue virus infection are dominated by highly cross-reactive, memory-derived plasmablasts
10.1128/jvi.03203-15 · 2016 · External reference
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model
10.1016/j.ebiom.2019.02.060 · 2019 · External reference
Single-cell deep phenotyping of IgG-secreting cells for high-resolution immune monitoring
10.1038/nbt.3964 · 2017 · External reference
Single-cell technologies for the study of antibody-secreting cells
10.3389/fimmu.2021.821729 · 2022 · External reference
Dynamic single-cell phenotyping of immune cells using the microfluidic platform DropMap
10.1038/s41596-020-0354-0 · 2020 · External reference
High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura
10.1172/jci153580 · 2022 · External reference
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics
10.1172/jci.insight.166602 · 2023 · External reference
Clinical and virological study of dengue cases and the members of their households: The multinational DENFRAME Project
10.1371/journal.pntd.0001482 · 2012 · External reference
National dengue surveillance, Cambodia 2002-2020
10.2471/blt.23.289713 · 2023 · External reference
Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus
10.1038/s41590-018-0227-7 · 2018 · External reference
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
10.1038/nsmb.1382 · 2008 · External reference
Structure-guided design of an anti-dengue antibody directed to a non-immunodominant epitope
10.1016/j.cell.2015.06.057 · 2015 · External reference
IgE plasma cells are transcriptionally and functionally distinct from other isotypes
10.1126/sciimmunol.adm8964 · 2024 · External reference
Opposing effects of pre-existing antibody and memory T cell help on the dynamics of recall germinal centers
10.1016/j.immuni.2024.05.009 · 2024 · External reference
Memory B cells
10.1038/s41577-023-00897-3 · 2024 · External reference
Germinal centers
10.1146/annurev-immunol-120419-022408 · 2022 · External reference
Impaired antibody-independent immune response of B cells in patients with acute dengue infection
10.3389/fimmu.2019.02500 · 2019 · External reference
Magnitude and kinetics of the human immune cell response associated with severe dengue progression by single-cell proteomics
10.1126/sciadv.ade7702 · 2023 · External reference
Immunophenotyping and transcriptional profiling of human plasmablasts in dengue
10.1128/jvi.00610-21 · 2021 · External reference
Human Ebola virus infection results in substantial immune activation
10.1073/pnas.1502619112 · 2015 · External reference
B-cell responses during primary and secondary dengue virus infections in humans
10.1093/infdis/jir607 · 2011 · External reference
Antibody and memory B cell responses to the dengue virus NS1 antigen in individuals with varying severity of past infection
10.1111/imm.13651 · 2023 · External reference
Multiplexed fluorospot for the analysis of dengue virus- and Zika virus-specific and cross-reactive memory B cells
10.4049/jimmunol.1800892 · 2018 · External reference
Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection
10.1371/journal.pone.0029430 · 2011 · External reference
Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes
10.4049/jimmunol.1201688 · 2012 · External reference
CD27hiCD38hi plasmablasts are activated B cells of mixed origin with distinct function
10.1016/j.isci.2021.102482 · 2021 · External reference
Human antibody response to dengue virus: Implications for dengue vaccine design
10.1186/s41182-016-0004-y · 2016 · External reference
Dengue and severe dengue
10.1128/cmr.00244-24 · 2025 · External reference
Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination
10.1126/scitranslmed.aaa3787 · 2015 · External reference
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis
2023 · External reference
The complexity of antibody-dependent enhancement of dengue virus infection
10.3390/v2122649 · 2010 · External reference
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
10.1186/1743-422x-7-28 · 2010 · External reference
Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus
10.1128/mbio.01123-16 · 2016 · External reference
Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective
10.1038/s41467-024-53916-9 · 2025 · External reference
Effect of dengue serostatus on dengue vaccine safety and efficacy
10.1056/nejmoa1800820 · 2018 · External reference
Increased adaptive immune responses and proper feedback regulation protect against clinical dengue
10.1126/scitranslmed.aal5088 · 2017 · External reference
Improved detection of dengue and Zika viruses using multiplex RT-qPCR assays
10.1016/j.jviromet.2020.113862 · 2020 · External reference
Unresolved reference
1997 · External reference
Spatial distribution and burden of emerging arboviruses in French Guiana
10.3390/v13071299 · 2021 · External reference
Toward a deeper understanding of dengue: Novel method for quantification and isolation of envelope protein epitope-specific antibodies
2025 · External reference
Temporal patterns of functional anti-dengue antibodies in dengue infected individuals with different disease outcome or infection history
10.1038/s41598-022-21722-2 · 2022 · External reference
Predominant autoantibody production by early human B cell precursors
10.1126/science.1086907 · 2003 · External reference
Unresolved reference
2017 · External reference
